The woman, who lives in Louisiana, lost around 150 pounds on the two medications, according to her attorney, Paul Pennock, a New York City-based attorney for Morgan & Morgan, According to the lawsuit, the woman, who has not been officially diagnosed with gastroparesis, suffered "severe gastrointestinal events," including, "severe vomiting, stomach pain, [and] gastrointestinal burning." "Her problems have been so severe that she's been to the emergency room multiple times, including last week," Pennock told ABC News Wednesday
Common side effects include nausea, diarrhea, constipation, vomiting and indigestion
Many users highlight this effect as a major factor in controlling late-night snacking or sugar-heavy cravings, making it easier to stick to healthy eating patterns
GLP-1 medications may contribute to nausea, constipation, and dehydration, making hydration important for digestion and overall well-being
Dose Escalation Schedule Based on the Phase 2 trial protocol, the escalation schedule for the 12mg maintenance cohort: How Retatrutide Dosing Compares to Other GLP-1 Peptides For a detailed head-to-head analysis, see our Semaglutide vs Retatrutide vs Tirzepatide Comparison
Instead of reserving GLP-1 receptor agonists for later stages, emerging evidence suggests starting sooner may improve outcomes and Read More Managing Rapid Improvement on GLP-1 Therapy: When to Adjust the Rest of the Regimen May 6, 2026 Articles, Blood Glucose Control, Blood Glucose Control, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Type 2 Diabetes, Type 2 Diabetes 1,535 views Rapid glycemic improvement with GLP-1 therapy is one of the most powerful benefits of modern diabetes care, but it can also create new clinical challenges
